US government exercises option to buy Bavarian smallpox vaccines for USD 119m
The first option in an existing contract with the US has been utilized, and Bavarian Nordic can start manufacturing freeze-dried doses of Jynneos for the country in 2023.
by albert rønning-andersson, translated by daniel pedersen
The US Biomedical Advanced Research and Development Authority (BARDA), which falls under the US Department of Health and Human Services, has exercised an option in a contract with Danish vaccine firm Bavarian Nordic, the firm has announced in a Wednesday press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
